Erratum to: First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012 (American Journal of Hematology, (2018), 93, 5, (643-648), 10.1002/ajh.25081)

Andrea BacigalupoRosi OnetoHubert SchrezenmeierBritta HochsmannCarlo DufourSeiji KojimaXiaofan ZhuXiaojuan ChenSurapol IssaragrisilSuporn ChuncharuneeDae Chul JeongSabrina GiammarcoMaria Teresa Van LintYizhou ZhengCarlos VallejoOspedale Policlinico San MartinoFondazione Policlinico Universitario Agostino Gemelli IRCCS Università Cattolica del Sacro CuoreChinese Academy of Medical SciencesIRCCS Istituto Giannina Gaslini - Ospedale PediatricoMahidol UniversityUniversität UlmHospital Universitario DonostiaThe Catholic University of KoreaNagoya University2019-08-282019-08-282018-05-01American Journal of Hematology. Vol.94, No.1 (2018), 16510968652036186092-s2.0-85058713753https://repository.li.mahidol.ac.th/handle/123456789/46737© 2018 Wiley Periodicals, Inc. We have a correction in the affiliations for Carlos Vallejo10. Correction: 10Hospital Universitario de Donostia, San Sebastian, Spain and PETHEMA- Spain.Mahidol UniversityMedicineErratum to: First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012 (American Journal of Hematology, (2018), 93, 5, (643-648), 10.1002/ajh.25081)ErratumSCOPUS10.1002/ajh.25138